|
Market Closed -
Deutsche Boerse AG
07:16:57 31/08/2026 BST
|
Pre-market 06:37:53 | |||
| 162.70 EUR | -3.78% |
|
163.10 | +0.25% |
| 08-21 | Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc. | CI |
| 08-21 | Ipsen Wraps Up Purchase of US-based Kartos Therapeutics | MT |
Company Valuation: Ipsen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,621 | 8,279 | 8,912 | 9,155 | 9,770 | 13,373 | - | - |
| Change | - | 25.05% | 7.65% | 2.72% | 6.72% | 36.88% | - | - |
| Enterprise Value (EV) 1 | 6,758 | 7,894 | 8,860 | 9,020 | 9,225 | 12,135 | 11,073 | 10,263 |
| Change | - | 16.81% | 12.22% | 1.81% | 2.28% | 31.53% | -8.75% | -7.31% |
| P/E | 10.4x | 12.9x | 14x | 26.7x | 22.4x | 13.6x | 13.9x | 14x |
| PBR | 2.42x | - | 2.36x | 2.22x | 2.3x | 2.62x | 2.22x | 1.92x |
| PEG | - | 20.02x | -13.67x | -0.6x | 0.8x | 0x | -6.24x | -23.26x |
| Capitalization / Revenue | 2.31x | 2.74x | 2.85x | 2.69x | 2.49x | 2.94x | 2.88x | 2.76x |
| EV / Revenue | 2.36x | 2.61x | 2.83x | 2.65x | 2.35x | 2.67x | 2.39x | 2.12x |
| EV / EBITDA | 5.8x | 5.86x | 10.1x | 7.52x | 6.67x | 6.41x | 6.24x | 5.73x |
| EV / EBIT | 6.68x | 7.08x | 8.85x | 8.13x | 7.13x | 7.33x | 7.34x | 6.87x |
| EV / FCF | 8.31x | 9.02x | 12.5x | 11.6x | 8.93x | 9.41x | 9.1x | 8.35x |
| FCF Yield | 12% | 11.1% | 8.02% | 8.59% | 11.2% | 10.6% | 11% | 12% |
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.535 | 1.532 | 1.655 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 0.94% | 0.94% | 1.01% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 12.02 | 11.75 | 11.68 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 12.8% | 13% | 14.2% |
| Net sales 1 | 2,869 | 3,025 | 3,128 | 3,401 | 3,929 | 4,543 | 4,637 | 4,840 |
| EBITDA 1 | 1,166 | 1,348 | 881.4 | 1,200 | 1,383 | 1,893 | 1,776 | 1,792 |
| EBIT 1 | 1,011 | 1,115 | 1,001 | 1,109 | 1,294 | 1,656 | 1,508 | 1,494 |
| Net income 1 | 646.6 | 647.5 | 647.2 | 347.3 | 444.5 | 1,011 | 985.4 | 981.3 |
| Net Debt 1 | 137.8 | -384.7 | -52.9 | -134.9 | -544.5 | -1,238 | -2,299 | -3,109 |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 163.10 | 163.10 | 163.10 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 11/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.44x | 12.14x | 24.6x | 0.59% | 1,031B | |
| 29.82x | - | - | 2% | 641B | |
| 32.73x | 7.6x | 15.79x | 2.67% | 453B | |
| 19.66x | 4.67x | 11.58x | 2.83% | 349B | |
| 21.66x | 5.59x | 13.87x | 2.87% | 290B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.19x | 7.03x | 12.5x | 2.35% | 232B | |
| 13.11x | 4.72x | 9.86x | 3.87% | 201B | |
| -44.72x | 6.46x | 25.22x | 2.25% | 181B | |
| Average | 17.08x | 6.56x | 15.71x | 2.39% | 403.31B | |
| Weighted average by Cap. | 24.14x | 8.04x | 17.77x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IPN Stock
- I7G Stock
- Valuation Ipsen
Select your edition
All financial news and data tailored to specific country editions
